Aptevo Therapeutics Inc. Depreciation
Aptevo Therapeutics Inc. (APVO) reported Depreciation of $200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-26
- Aptevo Therapeutics Inc. depreciation for fiscal 2025 was $200.00K, a 50.00% decline from fiscal 2024.
- Aptevo Therapeutics Inc. depreciation for fiscal 2024 was $400.00K, a 33.33% decline from fiscal 2023.
- Aptevo Therapeutics Inc. depreciation for fiscal 2023 was $600.00K, a 33.33% decline from fiscal 2022.
- Aptevo Therapeutics Inc. depreciation for fiscal 2022 was $900.00K, a 18.18% decline from fiscal 2021.
| Period end | Depreciation 6 month | Depreciation 12 month |
|---|---|---|
| 2025-12-31 | $200.00K 10-K · filed 2026-03-26 | |
| 2024-12-31 | $400.00K 10-K · filed 2026-03-26 | |
| 2023-12-31 | $600.00K 10-K · filed 2025-02-14 | |
| 2022-12-31 | $900.00K 10-K · filed 2024-03-05 | |
| 2021-12-31 | $1.10M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $1.20M 10-K · filed 2022-03-24 | |
| 2019-12-31 | $1.40M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $1.60M 10-K · filed 2020-03-25 | |
| 2017-12-31 | $1.50M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $1.10M 10-K · filed 2018-03-13 | |
| 2016-06-30 | $544.00K 10-Q/A · filed 2016-09-22 | |
| 2015-06-30 | $412.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |